Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam

Background: The World health organization (WHO) recently recommended standardized all-oral shorter regimens for rifampicin resistant Tuberculosis (RR-TB). For highly resistant Tuberculosis patients such as pre-XDR-TB: RR-TB plus additional resistance to fluoroquinolones (FQ), the 6–9-months bedaquil...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi Mai Phuong, Nguyen, Binh Hoa, Hoang, Thi Thanh Thuy, Nguyen, Hoang Anh, Vu, Dinh Hoa, Nguyen, Mai Hoa, Nguyen, Bao Ngoc, Decroo, Tom, Nguyen, Viet Nhung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614239/
https://www.ncbi.nlm.nih.gov/pubmed/36313324
http://dx.doi.org/10.3389/fphar.2022.1023704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614239/
https://www.ncbi.nlm.nih.gov/pubmed/36313324
http://dx.doi.org/10.3389/fphar.2022.1023704

Ejemplares similares